ϳԹ

Skip to main content

Health + Wellness

ϳԹ School of Medicine Researcher Discovers New “Anti-pathogenic” Drugs to Treat MRSA
CLEVELAND - Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the ϳԹ School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) har...
New Sporadic Prion Protein Disease Identified by ϳԹ
CLEVELAND - A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease (CJD) was reported in the 1920s. The landmark finding from the...
ϳԹ School of Medicine Awarded $4.7M Contract from Defense Advanced Research Projects Agency
CLEVELAND - Jonathan Stamler, MD, Director of the Institute for Transformative Molecular Medicine and the Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation at the ϳԹ and University Hospitals Harrington-McLaughlin Heart & V...
Susan G. Komen Awards ϳԹ School of Medicine Nearly $500,000 to Lead a Clinical Study Aimed to Improve Outcomes for Older Women with Breast Cancer
CLEVELAND - Cynthia Owusu, MD, associate professor at ϳԹ and geriatric-oncologist at University Hospitals Case Medical Center, the School’s primary affiliate, has received nearly $500,000 from Susan G. Komen For the Cure to fund a novel three-year study aimed at improvin...
Research Suggests Mechanism for the Link between High-Fat Diet and Risk of Prostate Cancer and Other Prostatic Disorders
CLEVELAND - Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostat...
ϳԹ-led Team Takes High Resolution Photo of a K+ Channel
CLEVELAND - Using chemical labeling and mass spectrometry-based techniques, Mark Chance, PhD, director of the ϳԹ School of Medicine Center for Proteomics and Bioinformatics and professor of physiology and biophysics; Sayan Gupta, PhD, instructor at the Case Center for Pr...
ϳԹ Center for Stem Cell and Regenerative Medicine and Athersys Receive $1M Third Frontier Grant to Support Research for Spinal Cord Injury
CLEVELAND - Athersys, Inc. (NASDAQ: ATHX) and its collaborators, including the Center for Stem Cell and Regenerative Medicine (CSCRM) and ϳԹ (ϳԹ), announced today that they have been awarded $1 million through the Ohio Third Frontier Biomedical Program to support resea...
ga_book_award_2022_banners_nominees_EN_Audrey_Selian_David_Cooperrider_S-1024x576_0.jpeg
Hero Type
Image
Josiah Macy, JR. Foundation Grant to Enhance Physician and Nursing Education With Student-Run Free Clinic and More at ϳԹ
CLEVELAND - ϳԹ's School of Medicine and Frances Payne Bolton School of Nursing have received a $640,000 grant from the Josiah Macy, Jr. Foundation to fund the new Interprofessional Learning Exchange and Development (I-LEAD) Program. The project will involve several exper...
Reported Surgical Quality Measures Not Associated With Lower Infection Rates
CLEVELAND - A study by investigators at ϳԹ School of Medicine published in this week’s issue of JAMA found that public hospital comparison data reported by the U.S. Department of Health and Human Services does not accurately correlate with a patient’s risk for surgical p...
Elia%20Casanova.png
Hero Type
Image
Major Jama Study Examines Cystic Fibrosis Survival Rates and MRSA Infections
CLEVELAND — A team of researchers led by Elliott Dasenbrook, MD, MHS, Assistant Professor of Medicine and Pediatrics at ϳԹ School of Medicine and Associate Director of the Adult Cystic Fibrosis Program at University Hospitals Case Medical Center’s Rainbow Babies & Childr...